William F. Doyle, Executive Chairman at NovoCure Ltd (NVCR), sold 15,856 shares at $134.12 ($2.1M) on 2021-04-01, disclosed to the SEC on 2021-04-02.
Open-market sale of $2.1M NVCR by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $134.12 | 7,928 | $1.1M | 50.0% |
| 2 | $134.12 | 7,928 | $1.1M | 50.0% |
| Total | $134.12 avg | 15,856 | $2.1M | 100% |
| Filing → |
| ELAN | BUY | 2024-03-12 | $245K | — | Filing → |
| NVCR | SELL | 2022-08-03 | $117K | — | Filing → |
| NVCR | SELL | 2022-03-09 | $334K | — | Filing → |